Bernadette Boden-Albala Selected Research

Bernadette Boden-Albala Research Topics

Disease

27	Stroke (Strokes) 11/2020 - 01/2002
12	Hypertension (High Blood Pressure) 11/2020 - 01/2002
10	Ischemic Stroke 07/2014 - 07/2003
7	Atherosclerosis 06/2010 - 01/2002
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 12/2002
6	Diabetes Mellitus 08/2010 - 01/2002
4	COVID-19 01/2022 - 01/2020
4	Infections 11/2021 - 01/2016
4	Myocardial Infarction 05/2011 - 11/2005
4	Coronary Artery Disease (Coronary Atherosclerosis) 08/2010 - 01/2002
3	Carotid Artery Diseases 07/2010 - 01/2002
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2010 - 02/2006
3	Inflammation (Inflammations) 04/2010 - 05/2005
3	Coronary Disease (Coronary Heart Disease) 01/2010 - 09/2008
2	Insulin Resistance 10/2010 - 10/2005
2	Noma (Nomas) 11/2009 - 06/2008
2	Obesity 02/2006 - 10/2005
2	Hyperlipidemias (Hyperlipidemia) 02/2006 - 11/2002
1	Human Influenza (Influenza) 11/2021
1	Transient Ischemic Attack 10/2015
1	Sleep Wake Disorders 01/2011
1	Periodontal Diseases (Periodontal Disease) 07/2010
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2009
1	Infarction (Infarctions) 09/2008
1	Heart Diseases (Heart Disease) 09/2008
1	Hyperglycemia 11/2005
1	Sleep Deprivation 10/2005
1	Vascular Diseases (Vascular Disease) 05/2005
1	Hypotension (Low Blood Pressure) 09/2003

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2011 - 05/2005
5	Blood Glucose (Blood Sugar)IBA 04/2010 - 02/2006
4	LipidsIBA 05/2011 - 03/2008
4	CholesterolIBA 06/2010 - 01/2008
4	HDL CholesterolIBA 04/2010 - 01/2002
4	LDL CholesterolIBA 11/2009 - 01/2002
3	Immunoglobulin G (IgG)IBA 11/2021 - 06/2021
3	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2014 - 02/2006
3	Glucose (Dextrose)FDA LinkGeneric 10/2010 - 11/2005
2	VaccinesIBA 01/2022 - 01/2022
2	Antihypertensive Agents (Antihypertensives)IBA 01/2017 - 07/2010
2	Lipoprotein(a)IBA 08/2010 - 01/2002
2	HomocysteineIBA 07/2010 - 10/2004
2	Triglycerides (Triacylglycerol)IBA 11/2009 - 01/2002
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2009 - 01/2002
2	C-Reactive ProteinIBA 07/2009 - 10/2006
2	Apolipoproteins AIBA 12/2002 - 01/2002
1	COVID-19 VaccinesIBA 01/2022
1	AntigensIBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	Calcibiotic Root Canal SealerIBA 12/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2015
1	PlasminogenIBA 07/2014
1	CalciumIBA 04/2010
1	Lipoproteins (Lipoprotein)IBA 04/2010
1	oxidized low density lipoproteinIBA 11/2009
1	InterleukinsIBA 07/2009
1	Dietary Fats (Dietary Fat)IBA 01/2009
1	A 19IBA 01/2008
1	LDL Lipoproteins (beta Lipoproteins)IBA 06/2007
1	Fibrinogen (Factor I)FDA Link 10/2006
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 10/2006
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2006
1	SaltsIBA 05/2006
1	LeptinIBA 10/2005
1	GhrelinIBA 10/2005
1	Interleukin-2 (IL2)IBA 05/2005
1	CytokinesIBA 05/2005
1	ORALIT (ORS)IBA 07/2003
1	Pyridinolcarbamate (P23)IBA 01/2003
1	Apolipoproteins B (ApoB)IBA 12/2002
1	ApolipoproteinsIBA 12/2002
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2002
1	aminoalcoholphosphotransferase (AAPT)IBA 11/2002
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2002
1	Apoprotein(a) (Apolipoprotein (a))IBA 01/2002
1	Protein Isoforms (Isoforms)IBA 01/2002

Therapy/Procedure

3	Length of Stay 10/2015 - 08/2010
1	Complementary Therapies (Alternative Medicine) 11/2020
1	Continuity of Patient Care 11/2020
1	Critical Care (Surgical Intensive Care) 01/2020
1	Secondary Prevention 01/2019
1	Patient Readmission 01/2016
1	Therapeutics 09/2008